Abstract
TO STUDY THE EFFICACY OF AYURVEDA-BASED COMPREHENSIVE DIABETIC CARE (CDC) PROGRAM IN OVERWEIGHT MALE TYPE-II DIABETIC PATIENTS

*Dr. Pallavi Patil Pawar, BAMS, MD and Dr. Diwakar Pawar, BAMS, FPC

ABSTRACT

In India, it is estimated that around 1/10th of the population is inflicted by DM, with significantly high mortality rates. Despite availability of plethora of therapeutic options for treatment of type II DM, its prevalence and contribution to global morbidity and mortality remains significantly high and is increasing continuously. The HbA1c levels are more important as it is an independent predictor of mortality and morbidity in diabetic patients and also reflects the average blood sugar control over the past 1-2 months. Hence, this study was conducted to evaluate the efficacy of Ayurveda-Based CDC program on Glycosylated hemoglobin (HbA1c) in overweight male Type-II DM Patients. Methods: This study was conducted from March 2017 to May 2018, Data of Type II DM patients who had received minimum 6 CDC sittings over 90 days(±15 days) and followed low carb diet plan in the out-patient departments(OPDs) at Madhavbaug clinics in Kolhapur, Maharashtra was identified. The patients were administered with Panchkarma therapy namely Snehana i.e. oleation, Swedana i.e. passive heat therapy and Basti of Gudmaar(Gymnema sylvestre), Daruharidra(Berberis aristate) and Yashtimadhu (Glycyrrhiza glabra) 100 ml Kwatha i.e. per rectal drug administration. In this study, the variables [HbA1c, weight, BMI, abdominal girth and dependency on medications] were assessed on day 1 and day 90 of CDC. Results: Fifteen male overweight male Type II diabetic patients were considered for analysis. There was significant improvement in HbA1c by 1.58%(from 8.38±1.24 to 6.8±0.52; p<0.001), weight by 4.05kg (from 76.37±8.09 to 72.31±8.17, p<0.001). BMI(from 27.44±2.28 to 25.87±2.05; p<0.001) and Abdominal girth(from 99.8±6.97 to 94.33±7.68; p<0.001) also showed significant reduction. Conclusion: Ayurveda-based CDC program found to be efficacious by reducing HbA1c in overweight male Type-II diabetic patients.

Keywords: Madhavbaug Daruharidra(Berberis aristate) and Yashtimadhu (Glycyrrhiza glabra) patients.


[Full Text Article]

Login





Forgot Password  |  Register

Indexing

Best Paper Awards

European Journal of Biomedical and Pharmaceutical Sciences (EJBPS) will give best paper award in every issue in the form of money along with certificate to promote research activity of scholar.

Best Article of current issue :

Tangudu Nagabhusana Rao

Download Article : Click here

News & Updation

  • NEW OCTOBER ISSUE PUBLISHED

    OCTOBER 2020 Issue has been successfully launched on 1 October 2020.

  • EJBPS New Impact Factor

    Its our Pleasure to Inform you that EJBPS Impact Factor has been increased from 5.467 to 6.044, due to high quality Publication at International Level.

  • Index Copernicus Value

    EJBPS Received Index Copernicus Value 77.3, due to High Quality Publication in EJBPS at International Level

  • Journal web site support Internet Explorer, Google Chrome, Mozilla Firefox, Opera, Saffari for easy download of article without any trouble.

    .

  • Article Invited for Publication

    Dear Researcher, Article Invited for Publication  in EJBPS coming Issue.

     

UG/PG/Ph.D Research Publication

Research Scholar of UG/PG/Ph.D can Submit their Research Article/Review Article/Case Study/Short Communication for Publication in EJBPS

Downloads

Copyright From

Covering Letter

                        Author Instruction 
 

PLAGERLUM REPORT